Dose/schedule finding study of palonosetron in sarcoma patients receiving multi-day chemotherapy with adriamycin and ifosfamide (AI).
Phase of Trial: Phase IV
Latest Information Update: 21 Mar 2013
At a glance
- Drugs Palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 15 Dec 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 15 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 May 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.